May 20, 2019 A coalition letter spearheaded by the Competitive Enterprise Institute (CEI) recently advocated for increasing a tax called […]
Gerard Scimeca – Chairman, CASE May 17, 2019 – https://bit.ly/2Vvy2Nx The American economy is, if nothing else, a land of […]
Gerard Scimeca – Chairman, CASE May 15, 2019 Democrats have once again upped the ante in their race to deny […]
May 12, 2019 – https://bit.ly/2JiRDi2 During a recent U.S. Senate hearing, Education Secretary Betsy Devos testified, “The vast majority of students […]
Gerard Scimeca – Chairman, CASE May 10, 2019 The end of the federal ban on sports betting should be a […]
Matthew Kandrach – President, CASE May 10, 2019 – https://bit.ly/2JbvgLv The taboo against hard-rock mining in the United States is nonsensical […]
Gerard Scimeca – Chairman, CASE May 3, 2019 – Despite the largely positive economic direction of the country, a stubborn […]
As consumers, we all understand the need to shop around. When buying gas, a TV or even a car we […]
Matthew Kandrach – President, CASE May 1, 2019 – https://bit.ly/2VG27hj Since the dawn of the internet, massive online theft of movies, […]
Gerard Scimeca – Chairman, CASE April 30, 2019 – https://bit.ly/2ZKASl7 History tells us that the first phone call was […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/